|
ABOUT COMPANY
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, researches and develops nanoparticle immunomodulatory drugs for the treatment and prevention of human disease. The company is headquartered in Watertown, Massachusetts.
|
EARNINGS
Gross Profit (TTM): -37908000
Market Capitalization: 380276000
Operating Margin (TTM): -0.247
PE Ratio: None
PEG Ratio: 0
Profit Margin: -0.795
Revenue Per Share (TTM): 0.6
Revenue (TTM): 67091000
Quarterly Earnings Growth YOY: 0
Quarterly Revenue Growth YOY: 4.258
Trailing PE: -
|
DIVIDENDS
Diluted EPS (TTM): -0.477
Dividend Date: None
Dividend Per Share: None
Dividend Yield: 0%
EBITDA: -57785000
ExDividend Date: None
Forward Annual Dividend Rate:
Forward Annual Dividend Yield:
|